VOLTAREN OPH SOLN Rx
Generic Name and Formulations:
Diclofenac sodium 0.1%.
Indications for VOLTAREN OPH SOLN:
Post-op inflammation after cataract extraction. Photophobia and pain in corneal refractive surgery.
Cataract surgery: 1 drop 4 times daily beginning 24 hrs post-op for 2 weeks. Corneal refractive surgery: 1–2 drops within the hour prior to surgery, then within 15 minutes post-op, then 4 times daily for up to 3 days.
Bleeding tendencies. Complicated or repeat ocular surguries. Corneal defects/denervation. Ocular surface diseases. Rheumatoid arthritis. Diabetes. May delay wound healing. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Should not be used by patients currently wearing soft contact lenses. Monitor refractive stability for 1 year. Pregnancy (Cat.C); avoid during late pregnancy. Nursing mothers: not recommended.
Caution with medications that prolong bleeding time. Concomitant use of topical steroids may increase potential for healing problems.
Burning, stinging, dry eye, other ocular effects, increased bleeding (including hyphemas).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Triiodothyronine in the Treatment of Bipolar Depression
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- E-Cigarettes Associated With More Harms Than Benefits at Population Level
- Examining Rates of Long-Term Opioid Use in Youth With Psychiatric Disorders
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Researchers Identify Novel Potential Biomarkers for Autism
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Personal Health Information Found in Recycling
- Nightmares in Military Personnel Frequently Comorbid With Mental Health Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Addressing Racial Disparities in Bipolar Disorder Treatment
- Negative Symptoms Increase Cardiovascular Risk in Schizophrenia